Researcher
Arnout Voet
- Disciplines:Biochemistry and metabolism, Systems biology, Medical biochemistry and metabolism
Affiliations
- Biochemistry, Molecular and Structural Biology (Division)
Member
From1 Nov 2004 → Today
Projects
1 - 10 of 38
- Symibs: a new class of designer intrabodies for the development of anticancer treatments targeting unstructured protein domains of MYC and p53.From1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Second generation lactic acid as a renewable platform for a circular bioeconomy (LAPLACE)From1 Oct 2023 → TodayFunding: FWO Strategic Basic Research (SBO)
- Integrated Strategy for Microbial Production of Lactic Acid and Ethyl Lactate from 2G FeedstockFrom28 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Design and functionalisation of a protein cageFrom5 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Design of self-assembled 2D layers based on artificial α/β propeller building blocksFrom1 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Targeting the androgen receptor dimerisation via computer-aided drug design and high throughput synthesis for prostate cancer therapy.From1 Sep 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Cooperativity between the androgen receptor and forkhead box A1 transcription factorFrom7 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- PHGDH-ASM: Phosphoglycerate dehydrogenase (PHGDH) activators as novel antiseizure medications (ASM) with dual mode of actionFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Computational design of symmetric β/α-propeller-proteins as building blocks for functional capsids and 2D arrays.From1 Oct 2022 → TodayFunding: BOF - projects
- PhD in biochemistry : functionalization of protein-based 2D arraysFrom25 May 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 104
- Rational evolution for altering the ligand preference of estrogen receptor alpha(2024)
Authors: Xiao Yin Lee, Karin Voordeckers, Els Henckaerts, Vitor Bernardes Pinheiro, Frank Claessens, Kevin Verstrepen, Arnout Voet, Christine Helsen
- Insights in inulin binding and inulin oligosaccharide formation by novel multi domain endo-inulinases from Botrytis cinerea(2024)
Authors: Arnout Voet, Wim Van den Ende
- Rational Design and Functionalization of an Artificial Scaffold Protein for Synthetic Biochemistry(2023)
Authors: Staf Wouters, Arnout Voet, Johan Robben
- A widely applicable and cost-effective method for specific RNA-protein complex isolation(2023)
Authors: Roosje Van Ende, Arnout Voet, Koen Geuten
- Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer(2023)
Authors: Christine Helsen, Xiao Yin Lee, Arnout Voet, Frank Claessens
- Computational design targeting the androgen receptor, CCR8 receptor, and NSP15 enzyme(2022)
Authors: Tien Nguyen, Arnout Voet, Wim Dehaen
- Exploiting Ligand-binding Domain Dimerization for Development of Novel Androgen Receptor Inhibitors(2022)
Authors: Christine Helsen, Tien Nguyen, Xiao Yin Lee, Nikolaos Louros, Joost Schymkowitz, Frederic Rousseau, Frank Claessens, Arnout Voet
Pages: 1823 - 1834 - Phloretin enhances remyelination by stimulating oligodendrocyte precursor cell differentiation(2022)
Authors: Esther Wolfs, Arnout Voet, Tien Nguyen
- Development of artificial nuclear receptors, the synthetic yeast approach(2022)
Authors: Roy Eerlings, Frank Claessens, Kevin Verstrepen, Arnout Voet, Christine Helsen
- A 1-aminocyclopropane-1-carboxylic-acid (ACC) dipeptide elicits ethylene responses through ACC-oxidase mediated substrate promiscuity(2022)
Authors: John Vaughan-Hirsch, Jolien Pattyn, Arnout Voet, Bram Van de Poel
Patents
1 - 6 of 6
- Thieno[2,3-b]pyridine derivatives as viral replication inhibitors (Inventor)
- Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors (Inventor)
- ;Antiviral compounds (Inventor)
- THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS (Inventor)
- NOVEL ANTIVIRAL COMPOUNDS (Inventor)
- VIRAL REPLICATION INHIBITORS (Inventor)